These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 4277357)

  • 1. Alternate complement pathways.
    Osler AG; Sandberg AL
    Prog Allergy; 1973; 17(0):51-92. PubMed ID: 4277357
    [No Abstract]   [Full Text] [Related]  

  • 2. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
    Cochrane CG; Müller-Eberhard HJ; Aikin BS
    J Immunol; 1970 Jul; 105(1):55-69. PubMed ID: 4246566
    [No Abstract]   [Full Text] [Related]  

  • 3. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 4. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
    Brade V; Vogt W
    Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
    [No Abstract]   [Full Text] [Related]  

  • 5. Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action.
    Koethe SM; Austen KF; Gigli I
    J Immunol; 1973 Feb; 110(2):390-400. PubMed ID: 4684033
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.
    Kane MA; May JE; Frank MM
    J Clin Invest; 1973 Feb; 52(2):370-6. PubMed ID: 4683877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of various antisera and cobra venom factor on inflammatory reactions in guinea-pig skin. II. The Arthus reaction and the local Shwartzman reaction.
    Lewis E; Turk JL
    J Pathol; 1975 Feb; 115(2):111-25. PubMed ID: 125318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS.
    WARD PA; COCHRANE CG
    J Exp Med; 1965 Feb; 121(2):215-34. PubMed ID: 14264268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decomplementization by a factor extracted from cobra venom. Effect on several immune reactions of the guinea pig and rat].
    Maillard JL; Zarco RM
    Ann Inst Pasteur (Paris); 1968 Jun; 114(6):756-74. PubMed ID: 4255485
    [No Abstract]   [Full Text] [Related]  

  • 10. [The third component of complement and complement receptors (author's transl)].
    Okuda T; Tachibana T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(9):657-67. PubMed ID: 4215099
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possible relationship between bacterial surface structures, immune-adherence, chemotaxis and phagocytosis (author's transl)].
    Kitzrow D; Blobel H
    Zentralbl Bakteriol Orig A; 1976 Jan; 234(1):129-35. PubMed ID: 1258564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 13. The complement system of man. I.
    Ruddy S; Gigli I; Austen KF
    N Engl J Med; 1972 Sep; 287(10):489-95. PubMed ID: 4114930
    [No Abstract]   [Full Text] [Related]  

  • 14. The biologic activities of guinea pig antibodies. I. Separation of gamma1 and gamma2 immunoglobulins and their participation in allergic reactions of the immediate type.
    Oliveira B; Osler AG; Siraganian RP; Sandberg AL
    J Immunol; 1970 Feb; 104(2):320-8. PubMed ID: 4189669
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the relation between the fifth component of complement and anaphylatoxinogen.
    Vogt W; Lufft E; Schmidt G
    Eur J Immunol; 1971 Apr; 1(2):141-5. PubMed ID: 4108378
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of the classic and alternate complement pathways by endotoxin.
    Fine DP
    J Immunol; 1974 Feb; 112(2):763-9. PubMed ID: 4205207
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenic effects of antigen-antibody reactions in vivo].
    Sordat B; Cottier H
    Bibl Haematol; 1967; 27():81-90. PubMed ID: 4174430
    [No Abstract]   [Full Text] [Related]  

  • 18. Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation.
    Goldstein IM; Brai M; Osler AG; Weissmann G
    J Immunol; 1973 Jul; 111(1):33-7. PubMed ID: 4197335
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaphylatoxin formation by contact activation of plasma. 3. Fixation of two different anaphylatoxin-forming complexes on zymosan.
    Brade V; Schmidt G; Vogt W
    Eur J Immunol; 1972 Apr; 2(2):180-6. PubMed ID: 4644242
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaphylatoxin in its relation to the complement system.
    Jensen J
    Science; 1967 Mar; 155(3766):1122-3. PubMed ID: 6021911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.